Humanigen Inc (HGENQ)

[cowtown jay]

The ACTIV5 trial completed enrollment on Jan 5th, 2022.

https://ir.humanigen.com/English/news/news-details/2022/Humanigen-Announces-Target-Enrollment-in-Phase-23-ACTIV-5BET-B-Trial-of-Lenzilumab-for-the-Treatment-of-COVID-19-has-Been-Achieved/default.aspx

Sixty day data for the last patient enrolled should have been available around March 5th. That gave management a topline data target for late Q1/early Q2, depending on how much time it took for the database lock.

There is no evidence to support that the database was not locked in March, as expected. That could mean that NIAID, which is Directed by Fauci, has delayed topline data by a full quarter.

I think your anger is misplaced.

https://www.niaid.nih.gov/about/director